CoraLite® Plus 488-conjugated AP5Z1/SPG48 Monoclonal antibody
AP5Z1/SPG48 Monoclonal Antibody for IF/ICC
Host / Isotype
Mouse / IgG1
Reactivity
Human, rat
Applications
IF/ICC
Conjugate
CoraLite® Plus 488 Fluorescent Dye
CloneNo.
1G1D7
Cat no : CL488-66533
Synonyms
Validation Data Gallery
Tested Applications
Positive IF/ICC detected in | HEK-293 cells |
Recommended dilution
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
CL488-66533 targets AP5Z1/SPG48 in IF/ICC applications and shows reactivity with Human, rat samples.
Tested Reactivity | Human, rat |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Immunogen | AP5Z1/SPG48 fusion protein Ag26961 |
Full Name | KIAA0415 |
Calculated Molecular Weight | 807 aa, 88 kDa |
Observed Molecular Weight | 88 kDa, 160 kDa |
GenBank Accession Number | BC037399 |
Gene Symbol | AP5Z1/SPG48 |
Gene ID (NCBI) | 9907 |
RRID | AB_2919340 |
Conjugate | CoraLite® Plus 488 Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 493 nm / 522 nm |
Form | Liquid |
Purification Method | Protein G purification |
Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
AP5Z1, also known as SPG48 and KIAA0415, is a part of AP-5. Biallelic mutations in the AP5Z1 gene encoding the AP5Z1 subunit have been described in a small number of patients with hereditary spastic paraplegia (HSP). AP5Z1 physically interacts with other HSP proteins and that patient cells are sensitive to DNA damaging drugs.
Protocols
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 AP5Z1/SPG48 antibody CL488-66533 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |